{"disease":{"id":"drug","name":"drug"},"drugs":{"marketed":[{"drug_id":"denosumab","indication_name":"Drug-induced osteoporosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prolia","generic_name":"DENOSUMAB","company_name":"Amgen","drug_phase":"marketed","molecular_target":"Tumor necrosis factor ligand superfamily member 11","drug_class":"RANK Ligand Inhibitor [EPC]","quality_score":60,"revenue":"6100","mechanism":"Prolia works by blocking a protein that breaks down bone."},{"drug_id":"lenacapavir","indication_name":"Multidrug resistant HIV-1 infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sunlenca","generic_name":"LENACAPAVIR","company_name":"Gilead Sciences","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":58,"revenue":"1600","mechanism":"Sunlenca works by binding to a specific site on the HIV-1 protease, preventing the virus from replicating."},{"drug_id":"hyaluronidase","indication_name":"Dispersion and Absorption of Injected Drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Wydase","generic_name":"HYALURONIDASE","company_name":"Baxter","drug_phase":"marketed","molecular_target":"hyaluronic acid","drug_class":"Endoglycosidase","quality_score":10,"revenue":"900","mechanism":"Hyaluronidase increases tissue permeability by breaking down hyaluronic acid, promoting the diffusion and absorption of injected fluids."},{"drug_id":"bedaquiline","indication_name":"Drug resistant tuberculosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sirturo","generic_name":"bedaquiline","company_name":"Janssen Therap","drug_phase":"marketed","molecular_target":"Potassium voltage-gated channel subfamily H member 2","drug_class":"Diarylquinoline Antimycobacterial","quality_score":75,"revenue":"400","mechanism":"Sirturo works by blocking the potassium voltage-gated channel subfamily H member 2, which is essential for the survival of Mycobacterium tuberculosis bacteria."},{"drug_id":"nalmefene","indication_name":"Poisoning by opiate analgesic drug","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Revex","generic_name":"NALMEFENE","company_name":"Hikma","drug_phase":"marketed","molecular_target":"Kappa-type opioid receptor","drug_class":"Opioid Antagonist","quality_score":55,"revenue":"400","mechanism":""},{"drug_id":"zithromax","indication_name":"To reduce the development of drug-resistant bacteria and maintain the effectiveness of ZITHROMAX and other antibacterial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zithromax","generic_name":"Azithromycin","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Not specified in label","drug_class":"Macrolide","quality_score":88,"revenue":"399","mechanism":"Azithromycin is a macrolide antibacterial drug."},{"drug_id":"phytonadione","indication_name":"Drug-induced hypoprothrombinemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PHYTONADIONE","company_name":"","drug_phase":"marketed","molecular_target":"Vitamin K epoxide reductase complex subunit 1 (VKORC1)","drug_class":"Vitamin K [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"naloxone","indication_name":"Poisoning by opiate analgesic drug","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Narcan","generic_name":"NALOXONE","company_name":"Adapt","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Antagonist","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"eflapegrastim-xnst","indication_name":"Febrile neutropenia caused by myelosuppressive anti-cancer drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"ROLVEDON","generic_name":"EFLAPEGRASTIM-XNST","company_name":"SPECTRUM PHARMS","drug_phase":"marketed","molecular_target":"Granulocyte colony-stimulating factor receptor","drug_class":"Leukocyte Growth Factor [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"vitamin-k1","indication_name":"Drug-induced hypoprothrombinemia caused by salicylates","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vitamin K1","generic_name":"Phytonadione","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Vitamin K-dependent carboxylase; vitamin K epoxide reductase complex (indirect antagonism of warfarin effects)","drug_class":"Vitamin K [EPC]","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"pyridoxine","indication_name":"Drug-Induced Pyridoxine Deficiency","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pyridoxine Hydrochloride","generic_name":"PYRIDOXINE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Cystathionine beta-synthase","drug_class":"Vitamin C [EPC]","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"eflapegrastim","indication_name":"Febrile neutropenia caused by myelosuppressive anti-cancer drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rolvedon","generic_name":"EFLAPEGRASTIM","company_name":"Spectrum Pharms","drug_phase":"marketed","molecular_target":"Granulocyte colony-stimulating factor receptor","drug_class":"Leukocyte Growth Factor [EPC]","quality_score":48,"revenue":null,"mechanism":"Rolvedon works by binding to the granulocyte colony-stimulating factor receptor, stimulating the production of white blood cells."},{"drug_id":"phytonadione","indication_name":"Other drug-induced hypoprothrombinemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PHYTONADIONE","company_name":"","drug_phase":"marketed","molecular_target":"Vitamin K epoxide reductase complex subunit 1 (VKORC1)","drug_class":"Vitamin K [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"imipenem","indication_name":"Infection caused by Acinetobacter spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"IMIPENEM","company_name":"Merck Sharp & Dohme B.V.","drug_phase":"marketed","molecular_target":"","drug_class":"imipenem","quality_score":70,"revenue":null,"mechanism":"Primaxin works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death."},{"drug_id":"imipenem","indication_name":"Infection caused by Citrobacter spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"IMIPENEM","company_name":"Merck Sharp & Dohme B.V.","drug_phase":"marketed","molecular_target":"","drug_class":"imipenem","quality_score":70,"revenue":null,"mechanism":"Primaxin works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death."},{"drug_id":"imipenem","indication_name":"Infection caused by Enterococcus spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"IMIPENEM","company_name":"Merck Sharp & Dohme B.V.","drug_phase":"marketed","molecular_target":"","drug_class":"imipenem","quality_score":70,"revenue":null,"mechanism":"Primaxin works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death."},{"drug_id":"imipenem","indication_name":"Infection caused by Escherichia coli strain resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"IMIPENEM","company_name":"Merck Sharp & Dohme B.V.","drug_phase":"marketed","molecular_target":"","drug_class":"imipenem","quality_score":70,"revenue":null,"mechanism":"Primaxin works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death."},{"drug_id":"imipenem","indication_name":"Infection caused by Pseudomonas aeruginosa strain resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"IMIPENEM","company_name":"Merck Sharp & Dohme B.V.","drug_phase":"marketed","molecular_target":"","drug_class":"imipenem","quality_score":70,"revenue":null,"mechanism":"Primaxin works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death."},{"drug_id":"imipenem","indication_name":"Infection caused by Serratia spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"IMIPENEM","company_name":"Merck Sharp & Dohme B.V.","drug_phase":"marketed","molecular_target":"","drug_class":"imipenem","quality_score":70,"revenue":null,"mechanism":"Primaxin works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death."},{"drug_id":"edrophonium","indication_name":"Neuromuscular Block due to Nondepolarizing Drug","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tensilon","generic_name":"EDROPHONIUM","company_name":"","drug_phase":"marketed","molecular_target":"Acetylcholinesterase","drug_class":"Cholinesterase Inhibitor","quality_score":36,"revenue":null,"mechanism":""},{"drug_id":"recombinant-antithrombin-rhat","indication_name":"Increasing the Dispersion and Absorption of Other Injected Drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Recombinant antithrombin (rhAT)","company_name":"Mayo Clinic","drug_phase":"marketed","molecular_target":"Hyaluronic acid and connective tissue polysaccharides","drug_class":"Dispersion agent; enzyme","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"pf-07941944","indication_name":"Please note that I am unable to verify the indications for this drug","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pf-07941944","generic_name":"pf-07941944","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Small molecule","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"pf-07941944","indication_name":"If you need to know the indications for this drug, I recommend checking the FDA website or other reliable sources","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pf-07941944","generic_name":"pf-07941944","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Not specified","drug_class":"Small molecule","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"cilastatin","indication_name":"Infection caused by Acinetobacter spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"CILASTATIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Dipeptidase 1","drug_class":"Renal Dehydropeptidase Inhibitor","quality_score":65,"revenue":null,"mechanism":"Primaxin works by inhibiting the action of dehydropeptidase, an enzyme that breaks down certain antibiotics, thereby protecting them from degradation and allowing them to reach effective concentrations in the body."},{"drug_id":"cilastatin","indication_name":"Infection caused by Citrobacter spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"CILASTATIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Dipeptidase 1","drug_class":"Renal Dehydropeptidase Inhibitor","quality_score":65,"revenue":null,"mechanism":"Primaxin works by inhibiting the action of dehydropeptidase, an enzyme that breaks down certain antibiotics, thereby protecting them from degradation and allowing them to reach effective concentrations in the body."},{"drug_id":"cilastatin","indication_name":"Infection caused by Enterococcus spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"CILASTATIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Dipeptidase 1","drug_class":"Renal Dehydropeptidase Inhibitor","quality_score":65,"revenue":null,"mechanism":"Primaxin works by inhibiting the action of dehydropeptidase, an enzyme that breaks down certain antibiotics, thereby protecting them from degradation and allowing them to reach effective concentrations in the body."},{"drug_id":"cilastatin","indication_name":"Infection caused by Escherichia coli strain resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"CILASTATIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Dipeptidase 1","drug_class":"Renal Dehydropeptidase Inhibitor","quality_score":65,"revenue":null,"mechanism":"Primaxin works by inhibiting the action of dehydropeptidase, an enzyme that breaks down certain antibiotics, thereby protecting them from degradation and allowing them to reach effective concentrations in the body."},{"drug_id":"cilastatin","indication_name":"Infection caused by Klebsiella spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"CILASTATIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Dipeptidase 1","drug_class":"Renal Dehydropeptidase Inhibitor","quality_score":65,"revenue":null,"mechanism":"Primaxin works by inhibiting the action of dehydropeptidase, an enzyme that breaks down certain antibiotics, thereby protecting them from degradation and allowing them to reach effective concentrations in the body."},{"drug_id":"cilastatin","indication_name":"Infection caused by Pseudomonas aeruginosa strain resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"CILASTATIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Dipeptidase 1","drug_class":"Renal Dehydropeptidase Inhibitor","quality_score":65,"revenue":null,"mechanism":"Primaxin works by inhibiting the action of dehydropeptidase, an enzyme that breaks down certain antibiotics, thereby protecting them from degradation and allowing them to reach effective concentrations in the body."},{"drug_id":"cilastatin","indication_name":"Infection caused by Serratia spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"CILASTATIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Dipeptidase 1","drug_class":"Renal Dehydropeptidase Inhibitor","quality_score":65,"revenue":null,"mechanism":"Primaxin works by inhibiting the action of dehydropeptidase, an enzyme that breaks down certain antibiotics, thereby protecting them from degradation and allowing them to reach effective concentrations in the body."},{"drug_id":"relebactam","indication_name":"Infection caused by Acinetobacter spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Recarbrio","generic_name":"RELEBACTAM","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"","drug_class":"Renal Dehydropeptidase Inhibitor [EPC]","quality_score":34,"revenue":null,"mechanism":"Recarbrio works by inhibiting the beta-lactamase enzymes produced by certain bacteria, allowing carbapenem antibiotics to effectively target and kill the bacteria."},{"drug_id":"relebactam","indication_name":"Infection caused by Citrobacter spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Recarbrio","generic_name":"RELEBACTAM","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"","drug_class":"Renal Dehydropeptidase Inhibitor [EPC]","quality_score":34,"revenue":null,"mechanism":"Recarbrio works by inhibiting the beta-lactamase enzymes produced by certain bacteria, allowing carbapenem antibiotics to effectively target and kill the bacteria."},{"drug_id":"relebactam","indication_name":"Infection caused by Enterococcus spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Recarbrio","generic_name":"RELEBACTAM","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"","drug_class":"Renal Dehydropeptidase Inhibitor [EPC]","quality_score":34,"revenue":null,"mechanism":"Recarbrio works by inhibiting the beta-lactamase enzymes produced by certain bacteria, allowing carbapenem antibiotics to effectively target and kill the bacteria."},{"drug_id":"relebactam","indication_name":"Infection caused by Escherichia coli strain resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Recarbrio","generic_name":"RELEBACTAM","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"","drug_class":"Renal Dehydropeptidase Inhibitor [EPC]","quality_score":34,"revenue":null,"mechanism":"Recarbrio works by inhibiting the beta-lactamase enzymes produced by certain bacteria, allowing carbapenem antibiotics to effectively target and kill the bacteria."},{"drug_id":"relebactam","indication_name":"Infection caused by Klebsiella spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Recarbrio","generic_name":"RELEBACTAM","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"","drug_class":"Renal Dehydropeptidase Inhibitor [EPC]","quality_score":34,"revenue":null,"mechanism":"Recarbrio works by inhibiting the beta-lactamase enzymes produced by certain bacteria, allowing carbapenem antibiotics to effectively target and kill the bacteria."},{"drug_id":"relebactam","indication_name":"Infection caused by Pseudomonas aeruginosa strain resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Recarbrio","generic_name":"RELEBACTAM","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"","drug_class":"Renal Dehydropeptidase Inhibitor [EPC]","quality_score":34,"revenue":null,"mechanism":"Recarbrio works by inhibiting the beta-lactamase enzymes produced by certain bacteria, allowing carbapenem antibiotics to effectively target and kill the bacteria."},{"drug_id":"relebactam","indication_name":"Infection caused by Serratia spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Recarbrio","generic_name":"RELEBACTAM","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"","drug_class":"Renal Dehydropeptidase Inhibitor [EPC]","quality_score":34,"revenue":null,"mechanism":"Recarbrio works by inhibiting the beta-lactamase enzymes produced by certain bacteria, allowing carbapenem antibiotics to effectively target and kill the bacteria."},{"drug_id":"idarucizumab","indication_name":"Drug-induced coagulation inhibitor disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Praxbind","generic_name":"IDARUCIZUMAB","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"dabigatran and its acylglucuronide metabolites","drug_class":"Humanized Monoclonal Antibody Fragment [EPC]","quality_score":10,"revenue":null,"mechanism":"Idarucizumab reverses dabigatran's anticoagulant effect by binding to it and its metabolites with high affinity."},{"drug_id":"delamanid","indication_name":"Drug resistant tuberculosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Deltyba","generic_name":"delamanid","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"","drug_class":"delamanid","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"probenecid","indication_name":"Adjunct Treatment to Inhibit Renal Drug Excretion","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Col-Probenecid","generic_name":"probenecid","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 9","drug_class":"probenecid","quality_score":10,"revenue":null,"mechanism":"ORLYNVAH combines sulopenem etzadroxil, a penem antibacterial, with probenecid to increase sulopenem's plasma concentration by inhibiting its renal clearance."},{"drug_id":"maraviroc","indication_name":"CCR5 Tropic Drug Resistant HIV Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Selzentry","generic_name":"MARAVIROC","company_name":"GSK","drug_phase":"marketed","molecular_target":"C-C chemokine receptor type 5","drug_class":"CCR5 Co-receptor Antagonist [EPC]","quality_score":75,"revenue":null,"mechanism":"Selzentry works by blocking the CCR5 receptor on immune cells, preventing HIV from entering and infecting these cells."},{"drug_id":"palifermin","indication_name":"Drug-induced mucositis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Kepivance","generic_name":"PALIFERMIN","company_name":"Biovitrum Ab","drug_phase":"marketed","molecular_target":"Fibroblast growth factor receptor 2","drug_class":"Mucocutaneous Epithelial Cell Growth Factor [EPC]","quality_score":60,"revenue":null,"mechanism":"Kepivance works by binding to fibroblast growth factor receptor 2, stimulating the growth and proliferation of mucosal cells."},{"drug_id":"prednisone","indication_name":"Drug hypersensitivity reactions","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Deltasone","generic_name":"prednisone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"selzentry","indication_name":"CCR5 Tropic Drug Resistant HIV Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Selzentry","company_name":"Icahn School of Medicine at Mount Sinai","drug_phase":"marketed","molecular_target":"Multidrug and toxin extrusion protein 1, C-C chemokine receptor type 5, C-C chemokine receptor type 5","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"vitamin-k1","indication_name":"Other drug-induced hypoprothrombinemia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vitamin K1","generic_name":"Phytonadione","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Vitamin K-dependent carboxylase; vitamin K epoxide reductase complex (indirect antagonism of warfarin effects)","drug_class":"Vitamin K [EPC]","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"pyrazinamide","indication_name":"Treatment of drug-resistant tuberculosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pyrazinamide","generic_name":"PYRAZINAMIDE","company_name":"Dava Pharms Inc","drug_phase":"marketed","molecular_target":"Cytochrome P450 3A4","drug_class":"Antimycobacterial [EPC]","quality_score":49,"revenue":null,"mechanism":""},{"drug_id":"pyrazinamide","indication_name":"Treatment after failure with other primary drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Pyrazinamide","generic_name":"PYRAZINAMIDE","company_name":"Dava Pharms Inc","drug_phase":"marketed","molecular_target":"Cytochrome P450 3A4","drug_class":"Antimycobacterial [EPC]","quality_score":49,"revenue":null,"mechanism":""},{"drug_id":"dexamethasone-phosphate","indication_name":"Drug hypersensitivity reactions","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dexamethasone Sodium Phosphate","generic_name":"dexamethasone phosphate","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Androgen receptor, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"acetazolamide","indication_name":"Drug-induced edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diamox","generic_name":"ACETAZOLAMIDE","company_name":"Teva","drug_phase":"marketed","molecular_target":"Carbonic anhydrase","drug_class":"Carbonic Anhydrase Inhibitor [EPC]","quality_score":53,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":49,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06801158","title":"Adverse Drug Reactions to Cancer Therapies in Patients with Depression: Insights from VigiBase","phase":"","overall_status":"COMPLETED","enrollment_count":8804863,"lead_sponsor_name":"University Hospital, Caen","has_results":false},{"nct_id":"NCT04662047","title":"The Impact of Air Pollution on the Consumption of Antimicrobials in the General Population","phase":"","overall_status":"UNKNOWN","enrollment_count":3249128,"lead_sponsor_name":"Hospital Universitari de Bellvitge","has_results":false},{"nct_id":"NCT05395897","title":"ORiginal meThodology for Assessing the Impact of the Coronavirus Health Crisis on Psychotropic Drug Use","phase":"","overall_status":"COMPLETED","enrollment_count":2772093,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT04740645","title":"NOCDURNA PASS Study Using Registries in Denmark, Germany and Sweden","phase":"","overall_status":"COMPLETED","enrollment_count":1099551,"lead_sponsor_name":"Ferring Pharmaceuticals","has_results":false},{"nct_id":"NCT03811470","title":"China Diabetes Registry by Metabolic Management Center","phase":"","overall_status":"RECRUITING","enrollment_count":1000000,"lead_sponsor_name":"Guang Ning","has_results":false},{"nct_id":"NCT05688761","title":"Nordic Gastric and Esophageal Tumor Study","phase":"","overall_status":"COMPLETED","enrollment_count":900000,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT05620056","title":"A Population-based Study of Drug Exposures and Adverse Pregnancy Outcomes in China (DEEP)","phase":"","overall_status":"COMPLETED","enrollment_count":564760,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT06483685","title":"Radiopharmaceuticals Analysis for Detailed Insights And INternational Tracking of Safety","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":500000,"lead_sponsor_name":"University Hospital, Caen","has_results":false},{"nct_id":"NCT04996732","title":"Long-term Survivorship of Discharged Patients With Malignant Tumor Based on Single-institutional Cancer Registry","phase":"","overall_status":"RECRUITING","enrollment_count":500000,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT05366621","title":"Post-fracture Medication and Mortality","phase":"","overall_status":"COMPLETED","enrollment_count":216155,"lead_sponsor_name":"National Cheng-Kung University Hospital","has_results":false},{"nct_id":"NCT04778969","title":"Kor PCI - CAD Patients Treated With PCI: Analysis of the Korean Nationwide Health Insurance Database","phase":"","overall_status":"UNKNOWN","enrollment_count":200000,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT06048276","title":"Miscarriage Preventing Herbal Medicines and the Risk of Birth Defects: a Population-based Cohort Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200000,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT05053828","title":"Type 2 Diabetes With Antiplatelet Drugs","phase":"","overall_status":"COMPLETED","enrollment_count":173464,"lead_sponsor_name":"Tabula Rasa HealthCare","has_results":false},{"nct_id":"NCT02668549","title":"Cross-Sectional Study to Define and Validate \"Doctor/Pharmacy Shopping\" as Outcomes Suggestive of Abuse and/or Addiction","phase":"","overall_status":"COMPLETED","enrollment_count":164923,"lead_sponsor_name":"Member Companies of the Opioid PMR Consortium","has_results":false},{"nct_id":"NCT07082465","title":"Epidemiology of Antimicrobial-use and Antimicrobial-resistant Infections in Four Hospitals in Thailand","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":108000,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT04279470","title":"Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse Events","phase":"","overall_status":"COMPLETED","enrollment_count":100000,"lead_sponsor_name":"Groupe Hospitalier Pitie-Salpetriere","has_results":false},{"nct_id":"NCT06135376","title":"E-PAUse: Encouraging Proper Antibiotic Use in Outpatient Setting","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Hamad Medical Corporation","has_results":false},{"nct_id":"NCT04791046","title":"Antihypertensive Therapy in Patients With Comorbidities","phase":"","overall_status":"UNKNOWN","enrollment_count":100000,"lead_sponsor_name":"Center of Personalized Medicine, Pirogova","has_results":false},{"nct_id":"NCT03294473","title":"Centralized Reminder Recall - Flu RCT2","phase":"NA","overall_status":"COMPLETED","enrollment_count":70190,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT06856772","title":"Randomized Comparison of Morning Versus Bedtime Administration of Statins: A Cardiovascular Circadian Chronotherapy (C3) Trial","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":42000,"lead_sponsor_name":"Tor Biering-Sørensen","has_results":false},{"nct_id":"NCT04615065","title":"Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine","phase":"","overall_status":"RECRUITING","enrollment_count":35000,"lead_sponsor_name":"University Medical Center Groningen","has_results":false},{"nct_id":"NCT06065852","title":"National Registry of Rare Kidney Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":35000,"lead_sponsor_name":"UK Kidney Association","has_results":false},{"nct_id":"NCT05932472","title":"Randomized Comparison of Morning Versus Bedtime Administration of Aspirin: A Cardiovascular Circadian Chronotherapy (C3) Trial","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":32706,"lead_sponsor_name":"Tor Biering-Sørensen","has_results":false},{"nct_id":"NCT05308303","title":"AI to Improve Data From Danish Cardiac Arrest Registry","phase":"","overall_status":"UNKNOWN","enrollment_count":31200,"lead_sponsor_name":"Prehospital Center, Region Zealand","has_results":false},{"nct_id":"NCT04381611","title":"INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma: Long-term Results and Success Predictors Analysed From a Large-scale Retrospective and Prospective Glaucoma Register","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"Dr. Kaweh Mansouri","has_results":false},{"nct_id":"NCT04692220","title":"Drug-Related Problems : Focus on Age and Diabetes","phase":"","overall_status":"COMPLETED","enrollment_count":27000,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT03349268","title":"Pulsed UV Xenon Disinfection to Prevent Resistant Healthcare Associated Infection","phase":"NA","overall_status":"COMPLETED","enrollment_count":25732,"lead_sponsor_name":"University of Michigan","has_results":true},{"nct_id":"NCT04336605","title":"Killing Pain - Use of Analgesic, Sedative and Anxiolytic Medication and the Development of Psychiatric Illness in Adolescents","phase":"","overall_status":"UNKNOWN","enrollment_count":25000,"lead_sponsor_name":"Norwegian Center for Violence and Traumatic Stress Studies","has_results":false},{"nct_id":"NCT05561504","title":"Helicobacter Pylori Local Prevalence and Antibiotic Resistance","phase":"","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Technical University of Munich","has_results":false},{"nct_id":"NCT03476733","title":"Incidence and Risk Factor of Drug Related Problem Detected in Inpatient","phase":"","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT05160233","title":"Digital Treatments for Opioids and Other Substance Use Disorders in Primary Care","phase":"NA","overall_status":"COMPLETED","enrollment_count":18430,"lead_sponsor_name":"Kaiser Permanente","has_results":true},{"nct_id":"NCT04119375","title":"Behavior Change and Digital Health Interventions for Improved TB Treatment Outcomes","phase":"NA","overall_status":"COMPLETED","enrollment_count":16146,"lead_sponsor_name":"Massachusetts Institute of Technology","has_results":false},{"nct_id":"NCT03442010","title":"Adverse Drug Events at Emergency Department","phase":"","overall_status":"COMPLETED","enrollment_count":13453,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT06847958","title":"HepC Micro-elimination on MSM and TGW Population.","phase":"","overall_status":"COMPLETED","enrollment_count":13161,"lead_sponsor_name":"Projecte dels NOMS Hispanosida","has_results":false},{"nct_id":"NCT04124250","title":"East New Britain Province Monitoring & Evaluation","phase":"","overall_status":"COMPLETED","enrollment_count":12930,"lead_sponsor_name":"University Hospitals Cleveland Medical Center","has_results":false},{"nct_id":"NCT04339634","title":"Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy","phase":"","overall_status":"COMPLETED","enrollment_count":12873,"lead_sponsor_name":"Tabula Rasa HealthCare","has_results":false},{"nct_id":"NCT03857100","title":"Improving Wisely - Polypharmacy","phase":"NA","overall_status":"COMPLETED","enrollment_count":11000,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT06732414","title":"A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT04619277","title":"Impact of Drug-coated Balloon Treatment in de Novo Coronary Lesion","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Ulsan Medical Center","has_results":false},{"nct_id":"NCT06044272","title":"Antimicrobial Resistance in Hospitals From Meta, Colombia","phase":"","overall_status":"COMPLETED","enrollment_count":10000,"lead_sponsor_name":"Hospital Departamental de Villavicencio","has_results":false},{"nct_id":"NCT04830241","title":"Neonatal Hypotonia Associated With in Utero Exposure to Antidepressant","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"University Hospital, Caen","has_results":false},{"nct_id":"NCT04633603","title":"LázBarát™ (FeverFriend™) Projekt: Attitude Toward Fever and Its Change in the Healthcare System","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":10000,"lead_sponsor_name":"University of Pecs","has_results":false},{"nct_id":"NCT06283316","title":"Systemic Treatments for Alopecia Areata Registry","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT04311359","title":"A Pharmacovigilance Study of Brain Oedema","phase":"","overall_status":"COMPLETED","enrollment_count":9524,"lead_sponsor_name":"University of Peshawar","has_results":false},{"nct_id":"NCT02208154","title":"Ecological Effects of Decolonisation Strategies in Intensive Care","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":8665,"lead_sponsor_name":"MJM Bonten","has_results":false},{"nct_id":"NCT06443385","title":"E-mails to Nudge Safer and Better-Informed Prescribing of Risky Drugs","phase":"NA","overall_status":"COMPLETED","enrollment_count":7872,"lead_sponsor_name":"Columbia University","has_results":false},{"nct_id":"NCT07431190","title":"British Columbia Prescriber Feedback Program - Antimicrobial Resistance","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":7626,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT07466784","title":"CEDRN: Opioid Registry","phase":"","overall_status":"RECRUITING","enrollment_count":7200,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT03093818","title":"PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions","phase":"NA","overall_status":"COMPLETED","enrollment_count":6950,"lead_sponsor_name":"J.J.Swen","has_results":false},{"nct_id":"NCT04293432","title":"A Pharmacovigilance Study of Torsade de Pointes","phase":"","overall_status":"COMPLETED","enrollment_count":6670,"lead_sponsor_name":"University of Peshawar","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}